nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0961	0.105	CbGbCtD
Methylphenobarbital—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0903	0.0986	CbGbCtD
Methylphenobarbital—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0903	0.0986	CbGbCtD
Methylphenobarbital—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0817	0.0892	CbGbCtD
Methylphenobarbital—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0685	0.0747	CbGbCtD
Methylphenobarbital—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0619	0.0676	CbGbCtD
Methylphenobarbital—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.061	0.0666	CbGbCtD
Methylphenobarbital—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0574	0.0627	CbGbCtD
Methylphenobarbital—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0519	0.0567	CbGbCtD
Methylphenobarbital—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0519	0.0567	CbGbCtD
Methylphenobarbital—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0448	0.0489	CbGbCtD
Methylphenobarbital—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0435	0.0475	CbGbCtD
Methylphenobarbital—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0393	0.0429	CbGbCtD
Methylphenobarbital—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0393	0.0429	CbGbCtD
Methylphenobarbital—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0377	0.0412	CbGbCtD
Methylphenobarbital—GRIK2—nerve—acquired immunodeficiency syndrome	0.00607	0.0734	CbGeAlD
Methylphenobarbital—CHRNA4—nerve—acquired immunodeficiency syndrome	0.00488	0.059	CbGeAlD
Methylphenobarbital—GRIK2—retina—acquired immunodeficiency syndrome	0.00251	0.0304	CbGeAlD
Methylphenobarbital—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.0024	0.0291	CbGeAlD
Methylphenobarbital—CHRNA7—retina—acquired immunodeficiency syndrome	0.00205	0.0248	CbGeAlD
Methylphenobarbital—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.00188	0.0228	CbGeAlD
Methylphenobarbital—CHRNA7—skin of body—acquired immunodeficiency syndrome	0.0018	0.0217	CbGeAlD
Methylphenobarbital—GRIA2—spinal cord—acquired immunodeficiency syndrome	0.00179	0.0217	CbGeAlD
Methylphenobarbital—CHRFAM7A—blood—acquired immunodeficiency syndrome	0.0017	0.0205	CbGeAlD
Methylphenobarbital—GRIK2—spinal cord—acquired immunodeficiency syndrome	0.00162	0.0196	CbGeAlD
Methylphenobarbital—GRIA2—nervous system—acquired immunodeficiency syndrome	0.00151	0.0183	CbGeAlD
Methylphenobarbital—GABRA6—nervous system—acquired immunodeficiency syndrome	0.00146	0.0177	CbGeAlD
Methylphenobarbital—GRIA2—central nervous system—acquired immunodeficiency syndrome	0.00145	0.0176	CbGeAlD
Methylphenobarbital—CHRNA7—digestive system—acquired immunodeficiency syndrome	0.00144	0.0174	CbGeAlD
Methylphenobarbital—CHRNA4—digestive system—acquired immunodeficiency syndrome	0.00142	0.0172	CbGeAlD
Methylphenobarbital—GABRA5—nervous system—acquired immunodeficiency syndrome	0.00142	0.0171	CbGeAlD
Methylphenobarbital—GABRA6—central nervous system—acquired immunodeficiency syndrome	0.0014	0.017	CbGeAlD
Methylphenobarbital—CHRFAM7A—nervous system—acquired immunodeficiency syndrome	0.00138	0.0167	CbGeAlD
Methylphenobarbital—CHRNA7—blood—acquired immunodeficiency syndrome	0.00137	0.0166	CbGeAlD
Methylphenobarbital—GRIK2—nervous system—acquired immunodeficiency syndrome	0.00136	0.0165	CbGeAlD
Methylphenobarbital—GABRA5—central nervous system—acquired immunodeficiency syndrome	0.00136	0.0165	CbGeAlD
Methylphenobarbital—CHRFAM7A—central nervous system—acquired immunodeficiency syndrome	0.00132	0.016	CbGeAlD
Methylphenobarbital—GABRA3—nervous system—acquired immunodeficiency syndrome	0.00132	0.0159	CbGeAlD
Methylphenobarbital—GRIK2—central nervous system—acquired immunodeficiency syndrome	0.00131	0.0159	CbGeAlD
Methylphenobarbital—CHRNA4—spinal cord—acquired immunodeficiency syndrome	0.0013	0.0158	CbGeAlD
Methylphenobarbital—GABRA4—nervous system—acquired immunodeficiency syndrome	0.00128	0.0155	CbGeAlD
Methylphenobarbital—GABRA3—central nervous system—acquired immunodeficiency syndrome	0.00127	0.0154	CbGeAlD
Methylphenobarbital—GABRA4—central nervous system—acquired immunodeficiency syndrome	0.00124	0.015	CbGeAlD
Methylphenobarbital—CHRNA4—lung—acquired immunodeficiency syndrome	0.00118	0.0143	CbGeAlD
Methylphenobarbital—GRIA2—brain—acquired immunodeficiency syndrome	0.00115	0.014	CbGeAlD
Methylphenobarbital—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.00113	0.0136	CbGeAlD
Methylphenobarbital—GABRA2—vagina—acquired immunodeficiency syndrome	0.00112	0.0136	CbGeAlD
Methylphenobarbital—GABRA6—brain—acquired immunodeficiency syndrome	0.00112	0.0135	CbGeAlD
Methylphenobarbital—CHRNA7—nervous system—acquired immunodeficiency syndrome	0.00111	0.0135	CbGeAlD
Methylphenobarbital—CHRNA4—nervous system—acquired immunodeficiency syndrome	0.0011	0.0133	CbGeAlD
Methylphenobarbital—GABRA5—brain—acquired immunodeficiency syndrome	0.00108	0.0131	CbGeAlD
Methylphenobarbital—CHRNA7—central nervous system—acquired immunodeficiency syndrome	0.00107	0.013	CbGeAlD
Methylphenobarbital—CHRNA4—central nervous system—acquired immunodeficiency syndrome	0.00106	0.0128	CbGeAlD
Methylphenobarbital—CHRFAM7A—brain—acquired immunodeficiency syndrome	0.00105	0.0127	CbGeAlD
Methylphenobarbital—GRIK2—brain—acquired immunodeficiency syndrome	0.00104	0.0126	CbGeAlD
Methylphenobarbital—GABRA3—brain—acquired immunodeficiency syndrome	0.00101	0.0122	CbGeAlD
Methylphenobarbital—GABRA4—brain—acquired immunodeficiency syndrome	0.000982	0.0119	CbGeAlD
Methylphenobarbital—GABRA2—nervous system—acquired immunodeficiency syndrome	0.000981	0.0119	CbGeAlD
Methylphenobarbital—GABRA1—nervous system—acquired immunodeficiency syndrome	0.000949	0.0115	CbGeAlD
Methylphenobarbital—GABRA2—central nervous system—acquired immunodeficiency syndrome	0.000945	0.0114	CbGeAlD
Methylphenobarbital—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000924	0.0112	CbGeAlD
Methylphenobarbital—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.000913	0.0111	CbGeAlD
Methylphenobarbital—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000904	0.0109	CbGeAlD
Methylphenobarbital—CYP2C19—blood—acquired immunodeficiency syndrome	0.00088	0.0106	CbGeAlD
Methylphenobarbital—CHRNA7—brain—acquired immunodeficiency syndrome	0.00085	0.0103	CbGeAlD
Methylphenobarbital—CHRNA4—brain—acquired immunodeficiency syndrome	0.000838	0.0101	CbGeAlD
Methylphenobarbital—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000816	0.00987	CbGeAlD
Methylphenobarbital—GABRA2—brain—acquired immunodeficiency syndrome	0.00075	0.00908	CbGeAlD
Methylphenobarbital—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000732	0.00886	CbGeAlD
Methylphenobarbital—GABRA1—brain—acquired immunodeficiency syndrome	0.000725	0.00877	CbGeAlD
Methylphenobarbital—GABRA2—lymph node—acquired immunodeficiency syndrome	0.000725	0.00877	CbGeAlD
Methylphenobarbital—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000723	0.00875	CbGeAlD
Methylphenobarbital—CYP2B6—blood—acquired immunodeficiency syndrome	0.000689	0.00834	CbGeAlD
Methylphenobarbital—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000639	0.00773	CbGeAlD
Methylphenobarbital—Fosphenytoin—ALB—acquired immunodeficiency syndrome	0.000615	0.49	CrCbGaD
Methylphenobarbital—CYP2B6—lung—acquired immunodeficiency syndrome	0.000604	0.00731	CbGeAlD
Methylphenobarbital—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000559	0.00677	CbGeAlD
Methylphenobarbital—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000538	0.00652	CbGeAlD
Methylphenobarbital—CYP2B6—brain—acquired immunodeficiency syndrome	0.000427	0.00517	CbGeAlD
Methylphenobarbital—Pethidine—ALB—acquired immunodeficiency syndrome	0.000369	0.294	CrCbGaD
Methylphenobarbital—Phenytoin—ALB—acquired immunodeficiency syndrome	0.000272	0.216	CrCbGaD
